Escin
- Generic Name
- Escin
- Drug Type
- Small Molecule
- Chemical Formula
- C110H172O48
- CAS Number
- 6805-41-0
- Unique Ingredient Identifier
- RUU8G67GQM
- Associated Conditions
- Concussion, Brain, Contusions, Inflammation, Inflammatory Reaction of the Lumbar Disc, Inflammatory Reaction of the Neck, Inflammatory Reaction of the Veins, Inflammatory Reaction of the spine, Lumbar Discogenic Pain (Disorder), Myalgia, Neck Pain, Spinal pain, Swelling of the Leg, Swelling of the Lumbar Disc, Swelling of the Neck, Swelling of the spine, Hematomas, Joint sprains, Localized swelling, Varicosities of the great saphenous vein
The Efficacy of Aescin in Combination With Micronized Purified Flavonoid Fraction (MPFF) in the Control of Bleeding and Prevent Recurrence of Acute Internal Hemorrhoids, A Randomized Controlled Trial, A Pilot Study
- First Posted Date
- 2024-12-24
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Chiang Mai University
- Target Recruit Count
- 120
- Registration Number
- NCT06748014
- Locations
- 🇹🇭
Chiangmai university, Chiangmai, Maung, Thailand
The Efficacy of Aescin in Combination With MPFF in the Early Control of Bleeding From Acute Internal Hemorrhoids, A Randomized Controlled Trial
Not Applicable
Not yet recruiting
- Conditions
- Anorectal Disorder
- Interventions
- Drug: Flavonoid
- First Posted Date
- 2024-04-12
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Chiang Mai University
- Target Recruit Count
- 60
- Registration Number
- NCT06363513
- Locations
- 🇹🇭
Maharaj Chiang Mai hospital, Chiangmai, Maung, Thailand
Escin in Patients With Covid-19 Infection
- First Posted Date
- 2020-03-26
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- University of Catanzaro
- Target Recruit Count
- 120
- Registration Number
- NCT04322344
- Locations
- 🇮🇹
Luca Gallelli, Catanzaro, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath